ID A0A2K5NFD6_CERAT Unreviewed; 1015 AA.
AC A0A2K5NFD6;
DT 28-MAR-2018, integrated into UniProtKB/TrEMBL.
DT 28-MAR-2018, sequence version 1.
DT 27-MAR-2024, entry version 28.
DE SubName: Full=Ubiquitin like modifier activating enzyme 6 {ECO:0000313|Ensembl:ENSCATP00000036035.1};
GN Name=UBA6 {ECO:0000313|Ensembl:ENSCATP00000036035.1};
OS Cercocebus atys (Sooty mangabey) (Cercocebus torquatus atys).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini;
OC Cercopithecidae; Cercopithecinae; Cercocebus.
OX NCBI_TaxID=9531 {ECO:0000313|Ensembl:ENSCATP00000036035.1, ECO:0000313|Proteomes:UP000233060};
RN [1] {ECO:0000313|Ensembl:ENSCATP00000036035.1}
RP IDENTIFICATION.
RG Ensembl;
RL Submitted (SEP-2023) to UniProtKB.
CC -!- PATHWAY: Protein modification; protein ubiquitination.
CC {ECO:0000256|ARBA:ARBA00004906}.
CC -!- SIMILARITY: Belongs to the ubiquitin-activating E1 family.
CC {ECO:0000256|ARBA:ARBA00005673}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR AlphaFoldDB; A0A2K5NFD6; -.
DR Ensembl; ENSCATT00000060323.1; ENSCATP00000036035.1; ENSCATG00000040804.1.
DR GeneTree; ENSGT00940000158826; -.
DR UniPathway; UPA00143; -.
DR Proteomes; UP000233060; Unplaced.
DR Bgee; ENSCATG00000040804; Expressed in pituitary gland and 12 other cell types or tissues.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0008641; F:ubiquitin-like modifier activating enzyme activity; IEA:InterPro.
DR GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.
DR CDD; cd01491; Ube1_repeat1; 1.
DR CDD; cd01490; Ube1_repeat2; 1.
DR Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR Gene3D; 2.40.30.180; Ubiquitin-activating enzyme E1, FCCH domain; 1.
DR Gene3D; 3.50.50.80; Ubiquitin-activating enzyme E1, inactive adenylation domain, subdomain 1; 2.
DR Gene3D; 3.40.50.12550; Ubiquitin-activating enzyme E1, inactive adenylation domain, subdomain 2; 1.
DR Gene3D; 1.10.10.2660; Ubiquitin-activating enzyme E1, SCCH domain; 1.
DR Gene3D; 3.10.290.60; Ubiquitin-activating enzyme E1, UFD domain; 1.
DR InterPro; IPR032420; E1_4HB.
DR InterPro; IPR032418; E1_FCCH.
DR InterPro; IPR042302; E1_FCCH_sf.
DR InterPro; IPR045886; ThiF/MoeB/HesA.
DR InterPro; IPR000594; ThiF_NAD_FAD-bd.
DR InterPro; IPR018965; Ub-activating_enz_E1_C.
DR InterPro; IPR042449; Ub-E1_IAD_1.
DR InterPro; IPR038252; UBA_E1_C_sf.
DR InterPro; IPR019572; UBA_E1_SCCH.
DR InterPro; IPR042063; Ubi_acti_E1_SCCH.
DR InterPro; IPR035985; Ubiquitin-activating_enz.
DR InterPro; IPR018075; UBQ-activ_enz_E1.
DR InterPro; IPR000011; UBQ/SUMO-activ_enz_E1-like.
DR NCBIfam; TIGR01408; Ube1; 1.
DR PANTHER; PTHR10953; UBIQUITIN-ACTIVATING ENZYME E1; 1.
DR PANTHER; PTHR10953:SF186; UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 6; 1.
DR Pfam; PF16191; E1_4HB; 1.
DR Pfam; PF16190; E1_FCCH; 1.
DR Pfam; PF09358; E1_UFD; 1.
DR Pfam; PF00899; ThiF; 2.
DR Pfam; PF10585; UBA_E1_SCCH; 2.
DR PRINTS; PR01849; UBIQUITINACT.
DR SMART; SM00985; UBA_e1_C; 1.
DR SUPFAM; SSF69572; Activating enzymes of the ubiquitin-like proteins; 2.
PE 3: Inferred from homology;
KW Ligase {ECO:0000256|ARBA:ARBA00022598};
KW Reference proteome {ECO:0000313|Proteomes:UP000233060}.
FT DOMAIN 884..1006
FT /note="Ubiquitin-activating enzyme E1 C-terminal"
FT /evidence="ECO:0000259|SMART:SM00985"
FT REGION 1..21
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 1015 AA; 113823 MW; F2079C17EB0F072B CRC64;
MEGSKPVAAP QGEEASCSSW GTGSTNKNLP IMSTASVEID DALYSRQRYV LGDTAMQKMA
KSYVFLSGMG GLGLEIEKCQ AWDLGTNFFL SEDDVVNKRN RAEAVLKHIA ELNPYVHVTS
SSVPFNETTD LSFLDKYQCV VLTEMKLPLQ KKINDFCRSQ CPPIKFISAD VHGIWSRLFC
DFGDEFEVLD ATGEEPKEIF ISNITQANPG IVTCLENHPH KLETGQFLTF REINGMTGLN
GSIQQITVIS PFSFSIGDTT ELEPYLHGGI AVQVKTPKTV FFEPLERQIK HPKCLIVDFS
KPEAPLEIHT AMLALDQFQE KYSRKPNVGC QQDSEELLKL ATSVSETLEE KPDVNADIVH
WLSWTAQGFL SPLAAAVGGV ASQEVLKAVT GKFSPLCQWL YLEAADIVES LGKPECEEFL
PRGDRYDALR ACIGDTLCQK LQNLNIFLVG CGAIGCEMLK NFALLGVGTS KEKGMITVTD
PDLIEKSNLN RQFLFRPHHI QKPKSYTAAD ATLKINSQIK IDAHLNKVCP ATETIYNDEF
CTKQDIIITA LDNVEARRYV DSRCLANLRP LLDSGTMGTK GHTEVIVPHL TESYNSHRDP
PEEEIPFCTL KSFPAAIEHT IQWARDKFES SFSHKPSLFN KFWQTYSSAE EVLQKIQSGH
SLEGCFQVIK LLSRRPRNWS QCVELARLKF EKYFNHKALQ LLHCFPLDIR LKDGSKHLSF
LQNAAKLYAT VYCIPFTEED LSADALLNIL SEVKIQEFKP SNKVVQTDET ARKPDHVPIS
SEDERNAIFQ LEKAILSNEA TKSDLQMAVL SFEKDDDHNG HIDFITAASN LRAKMYSIEP
ADRFKTKRVA GKIIPAIATT TATVSGLVAL EMIKVTGGYP FEAYKNCFLN LAIPIIVFTE
TSEVRKTKIR NEISFTIWDR WTVHGKEDFT LLDFINAVKE KYGIEPTMVV QGVKMLYVPV
MPGHAKRLKL TMHKLVKPST EKKYVDLTVS FAPDIDGDED LPGPPVRYYF SHDTD
//